Abiopharma

News list

Director Baker Bridget 🟡 adjusted position in 0 shares (1 derivative) of LiveOne, Inc. (LVO) Transaction Date: Mar 31, 2026 | Filing ID: 039672

Full text

News bot April 3, 2026, 1:01 a.m.
🔍 Baker Bridget (Director)

Company: LiveOne, Inc. (LVO)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 21,153
- Total shares sold: 21,153
Detailed Transactions and Holdings:
- Acquired 21,153 shares of Common Stock, $0.001 par value (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 268,684.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 21,153 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Restricted Stock Units convert into the Issuer's common stock on a one-for-one basis.
- F2: Represents vested Restricted Stock Units (the "RSUs") that were settled on the reported date, which RSUs were previously granted to the Reporting Person as director fees for service on the Issuer's board of directors for the period from October 1, 2024 to September 30, 2025. Each vested RSU was settled by the Issuer by delivery to the Reporting Person of one share of Issuer's common stock.